N1VO34:BVMF
Նովո Նորդիսկ
28,08 R$
0,00%
(0,00) 1D
18 սեպ, 17:06:00 GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for N1VO34...
Open
28,10 R$
High
28,10 R$
Low
27,59 R$
Mkt. cap
145,43 մլրդ
Avg. vol.
25,86 հզր
Volume
6,63 հզր
52-wk high
42,43 R$
52-wk low
22,90 R$
Shares outstanding
3,39 մլրդ
No. of employees
67 հզր
Open
28,10 R$
High
28,10 R$
Low
27,59 R$
Mkt. cap
145,43 մլրդ
Avg. vol.
25,86 հզր
Volume
6,63 հզր
52-wk high
42,43 R$
52-wk low
22,90 R$
Shares outstanding
3,39 մլրդ
No. of employees
67 հզր
News stories
From web sources and news partners
Stock Titan
·
19 ժամ առաջ
A weekly shot may become Europe’s first approved growth-hormone treatment for children with unexplained shortness
Traders Union
·
21 ժամ առաջ
Can Anthropic partnership spark further gains for Novo Nordisk stock?
BioPharma Dive
·
1 օր առաջ
Novo partners with Orbis, deepening investment in oral peptide drugs
Stocktwits
·
1 օր առաջ
NVO Stock Jumps 4% As European Committee Backs Novo’s Haemophilia Pen
Profile
Novo is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices.
Novo employs more than 48,000 people globally, and markets its products in 168 countries. The corporation was created in 1989, through a merger of two Danish companies, which date back to the 1920s. Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights, while spin-off company Novozymes was named fourth. It is a leader in the FTSE4Good Index, and the only European company in the top ten. Novo is the largest pharmaceutical company in Denmark. Wikipedia
About Նովո Նորդիսկ
CEOMaziar Mike Doustdar
Employees66,7 հզր
Founded21 դեկ, 1923 թ.
HeadquartersBagsværd, Մայրաքաղաքային տարածաշրջան, Դանիա
Sector-
Websitenovonordisk.com